In comparison to the global demand, the production volumes planned by SBIL in 2011 (first year of operation) constitute a small fraction of less than 2% of global demand for majority products, and this would enable the company to penetrate into the market with ease and remain viable in the years to come.
Considering the normal trend of fermentation products (which depends on various factors like importance of the product, competition, demand and supply) SBIL has taken adequate cushion in pricing the products to sustain in the market.
SBIL has 100% buy back arrangement with M/s Arch Pharmalabs Limited, Mumbai, India. This arrangement is made as a matter of abundant caution to ensure international market share. In addition, SBIL will have its own agents to market the products.
Over a period of time the company will have an exclusive marketing Division headed by Vice-President (marketing) who will in turn be assisted by marketing managers looking after export and domestic markets.